Mrs Jenelle S Miller, MD | |
8301 Harcourt Rd, Suite 200, Indianapolis, IN 46260-2081 | |
(317) 415-6600 | |
(317) 415-6649 |
Full Name | Mrs Jenelle S Miller |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 26 Years |
Location | 8301 Harcourt Rd, Indianapolis, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114926060 | NPI | - | NPPES |
200497270 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RX0202X | Internal Medicine - Medical Oncology | 01059206 (Indiana) | Secondary |
207RH0003X | Internal Medicine - Hematology & Oncology | 01059206 (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hospital | Logansport, IN | Hospital |
Ascension St Vincent Hospital | Indianapolis, IN | Hospital |
Ascension St Vincent Carmel | Carmel, IN | Hospital |
Witham Health Services | Lebanon, IN | Hospital |
Ascension St Vincent Fishers | Fishers, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
American Oncology Partners Pa | 0042569758 | 191 |
Memorial Hospital | 8123923281 | 73 |
News Archive
Asahi Kasei Pharma America Corp. today announced the initiation of an 800-patient Phase 3 clinical trial for ART-123 (recombinant human thrombomodulin, marketed as Recomodulin in Japan) in severe sepsis patients with coagulopathy.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
Visual rehabilitation will continue to increase in importance in the near future, particularly because the number of older patients is rising. Susanne Trauzettel-Klosinski summarizes the present state of knowledge in the current issue of the Deutsches Ärzteblatt International.
Multi-vitamin products, nutritional supplements and parents tout the need for such mineral elements as calcium, zinc, phosphorus, iron and others.
Professional baseball players who score higher on a test of hand-eye coordination have better batting performance – particularly in drawing walks and other measures of "plate discipline," reports a study in the July issue of Optometry and Vision Science, the official journal of the American Academy of Optometry.
› Verified 8 days ago
Entity Name | Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942317656 PECOS PAC ID: 8123923281 Enrollment ID: O20031206000001 |
News Archive
Asahi Kasei Pharma America Corp. today announced the initiation of an 800-patient Phase 3 clinical trial for ART-123 (recombinant human thrombomodulin, marketed as Recomodulin in Japan) in severe sepsis patients with coagulopathy.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
Visual rehabilitation will continue to increase in importance in the near future, particularly because the number of older patients is rising. Susanne Trauzettel-Klosinski summarizes the present state of knowledge in the current issue of the Deutsches Ärzteblatt International.
Multi-vitamin products, nutritional supplements and parents tout the need for such mineral elements as calcium, zinc, phosphorus, iron and others.
Professional baseball players who score higher on a test of hand-eye coordination have better batting performance – particularly in drawing walks and other measures of "plate discipline," reports a study in the July issue of Optometry and Vision Science, the official journal of the American Academy of Optometry.
› Verified 8 days ago
Entity Name | Riverview Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609074921 PECOS PAC ID: 1153216627 Enrollment ID: O20040216000572 |
News Archive
Asahi Kasei Pharma America Corp. today announced the initiation of an 800-patient Phase 3 clinical trial for ART-123 (recombinant human thrombomodulin, marketed as Recomodulin in Japan) in severe sepsis patients with coagulopathy.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
Visual rehabilitation will continue to increase in importance in the near future, particularly because the number of older patients is rising. Susanne Trauzettel-Klosinski summarizes the present state of knowledge in the current issue of the Deutsches Ärzteblatt International.
Multi-vitamin products, nutritional supplements and parents tout the need for such mineral elements as calcium, zinc, phosphorus, iron and others.
Professional baseball players who score higher on a test of hand-eye coordination have better batting performance – particularly in drawing walks and other measures of "plate discipline," reports a study in the July issue of Optometry and Vision Science, the official journal of the American Academy of Optometry.
› Verified 8 days ago
Entity Name | American Oncology Partners Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265929723 PECOS PAC ID: 0042569758 Enrollment ID: O20190409000760 |
News Archive
Asahi Kasei Pharma America Corp. today announced the initiation of an 800-patient Phase 3 clinical trial for ART-123 (recombinant human thrombomodulin, marketed as Recomodulin in Japan) in severe sepsis patients with coagulopathy.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
Visual rehabilitation will continue to increase in importance in the near future, particularly because the number of older patients is rising. Susanne Trauzettel-Klosinski summarizes the present state of knowledge in the current issue of the Deutsches Ärzteblatt International.
Multi-vitamin products, nutritional supplements and parents tout the need for such mineral elements as calcium, zinc, phosphorus, iron and others.
Professional baseball players who score higher on a test of hand-eye coordination have better batting performance – particularly in drawing walks and other measures of "plate discipline," reports a study in the July issue of Optometry and Vision Science, the official journal of the American Academy of Optometry.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Jenelle S Miller, MD Po Box 749495, Atlanta, GA 30374-9495 Ph: (239) 432-8331 | Mrs Jenelle S Miller, MD 8301 Harcourt Rd, Suite 200, Indianapolis, IN 46260-2081 Ph: (317) 415-6600 |
News Archive
Asahi Kasei Pharma America Corp. today announced the initiation of an 800-patient Phase 3 clinical trial for ART-123 (recombinant human thrombomodulin, marketed as Recomodulin in Japan) in severe sepsis patients with coagulopathy.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.
Visual rehabilitation will continue to increase in importance in the near future, particularly because the number of older patients is rising. Susanne Trauzettel-Klosinski summarizes the present state of knowledge in the current issue of the Deutsches Ärzteblatt International.
Multi-vitamin products, nutritional supplements and parents tout the need for such mineral elements as calcium, zinc, phosphorus, iron and others.
Professional baseball players who score higher on a test of hand-eye coordination have better batting performance – particularly in drawing walks and other measures of "plate discipline," reports a study in the July issue of Optometry and Vision Science, the official journal of the American Academy of Optometry.
› Verified 8 days ago
Irene A Carrothers, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 Senate Blvd, Indianapolis, IN 46202 Phone: 317-963-8776 Fax: 317-963-5285 | |
Liam P Howley, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1001 West 10th St Opw-m200, Indiana University Department Of Medicine, Indianapolis, IN 46202 Phone: 317-630-6560 | |
Cristina Nancy Perez Chumbiauca, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-5000 | |
Dr. Andrew Jonathen Ortega, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 702 Rotary Cir, Indianapolis, IN 46202 Phone: 317-278-4427 | |
Lawrence John Born, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8424 Naab Rd, #3-j, Indianapolis, IN 46260 Phone: 317-872-7396 Fax: 317-879-8328 | |
Brian T Robinson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-7979 Fax: 317-630-2668 | |
Steven T Hugenberg, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-8660 |